Eva Medtec (2023)
About this raise
Eva Medtec, with a valuation of $11,030,000, is raising funds on Startengine. They make it possible for anyone to experience the benefits of automated lymphatic therapy with one simple, at-home system. Eva Medtec is targeting the $4B Pain Management Devices market. They have created and manufactured Neuroglide™, an over the counter, FDA-cleared medical device engineered to automate and emulate manual lymphatic drainage (MLD) therapy. Irene Waldridge founded Eva Medtec in 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,234,999. The campaign proceeds will be used for company employment, inventory, working capital and clinical studies.
Investment Overview
Invested $130,534 :
Deal Terms
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Low
- Capital Intensity
- High
Financials
-
Revenue
-
$68,149
as of FY2021
- Monthly Burn
-
$73,758
as of FY2021
-
Runway
-
0.3 months
as of FY2021
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $1,014,500
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
03/05/2025 | Andes Capital | $22,626,135 | $0 | Equity - Common | Not Funded | RegCF |
06/30/2023 | Netcapital | $8,997,823 | $0 | Equity - Common | Not Funded | RegCF |
03/20/2023 | StartEngine | $11,030,000 | $130,534 | Equity - Common | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.